Alacrita's technical and scientific expertise allows it to deeply understand the science behind biotech and pharmaceutical assets - a core advantage in all business development work that we do. Whether it’s in the ability to recognize potential assets when scouting, in developing the right assumptions for a valuation model, or with delivering due diligence that provides a complete and accurate assessment, knowing the science makes us more effective.
Our consultants average 20-30 years of industry experience and bring significant first-hand knowledge to every project. Our core team works hand in hand with our Expert Network, which contains over 100 expert business development consultants, and more than 500 high-caliber consultants in total. Having this substantial resource at our fingertips allows us to provide precisely relevant expertise tailored to the specifics of each project, across a full range of product modalities and disease areas.